ADORA2A and Alzheimer disease: OtherAre anti‐diabetic drugs (e.g., long‐acting analog of glucagon‐like peptide‐1) novel potential therapies for AD?Is it possible to create new non‐canonical classes of therapeutic drugs for AD (e.g., adenosine receptor A2A‐targeted, tryptophan metabolite‐based, or vitamin K‐based)304, 305, 306?Okadaic acid is known to cause neuroinflammation and dysfunction of the cholinergic system in rodents.148 Does it have the same effect in zebrafish?Do drugs that are used in pharmacological models (e.g., streptozotocin) cause same or opposite effects in different model objects across taxa?